Laddar…
Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
We compared the efficacy and the safety of a carboplatin plus etoposide regimen (CE) vs split doses of cisplatin plus etoposide (SPE) in elderly or poor-risk patients with extensive disease small-cell lung cancer (ED-SCLC). Eligibility criteria included: untreated ED-SCLC; age ⩾70 and performance st...
Huvudupphovsmän: | , , , , , , , , , |
---|---|
Materialtyp: | Text |
Språk: | English |
Publicerad: |
Nature Publishing Group
2007
|
Ämnen: | |
Länkar: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360311/ https://www.ncbi.nlm.nih.gov/pubmed/17579629 http://dx.doi.org/10.1038/sj.bjc.6603810 |